Have you been diagnosed with Hodgkin's Lymphoma. Are you looking for options to treat cancer ?If so, you may be able to take part in a research study looking at the safety of giving a new drug called ATLCAR.CD30.CCR4

Have you been diagnosed with diffuse large B-cell lymphoma? Have you already received treament for your cancer, but it either came back or did not improve? Then you may be eligible for a study to look at the safety and effectiveness of the combination of treatments with rituximab, gemcitabine, dexamethasone, cisplatin and the study drug polatuzumab vedotin

The purpose of this study is to better understand how young adults (ages 18 - 39) who have had cancer use entertainment media during and after cancer treatment.

African American communities have been disproportionately affected by the burdens of cancer, yet their experiences and voices remain underrepresented in health research. In this study, we want to understand the experiences and perspectives of African American/Black individuals who support or care for their loved ones diagnosed with cancer.

Are you a patient or survivor of a pediatric or young adult cancer? You may be able to take part in this registry to help us learn about long-term and treatment-related adverse outcomes.

Have you been recently diagnosed with Diffuse Large B Cell Lymphoma? Are you over 75 years of age? If so, you may be able to take part in a research study looking at the safety of giving a new study drug CC-486 (oral azacitidine) in addition to the standard chemotherapy drug combination used to treat this disease.

Do you have cancer? Are you about to start immunotherapy? You may be able to participate in a research study to help answer many questions that still exist about immunotherapy like - Who is more likely to get side effects? What treatments will help control the side effects but let patients continue their cancer treatment? What factors can affect the type of side effects patients have (type of cancer or immunotherapy? previous chemo or radiation? existing autoimmune diseases?, etc.) and more.

Do you have mantle cell lymphoma or other non-Hodgkin lymphoma that has either come back or did not get better with your last treatment? If so, you may be able to take part in a study that will modify your own immune cells to see if it may treat your cancer.

This phase I trial is to find out the best dose, possible benefits and/or side effects of lenalidomide when added to nivolumab and the usual drugs (rituximab and methotrexate) in patients with primary central nervous system (CNS) lymphoma.

Have you been diagnosed with central nervous system (CNS) lymphoma? Have you received treatment for this disease, but it either came back or did not improve? Then you may be eligible to participate ind a study to look at the safety and effectiveness of the new study drug acalabrutinib.